当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.
The Lancet ( IF 168.9 ) Pub Date : 2017-08-01 , DOI: 10.1016/s2213-2600(17)30110-8
Camelia Savulescu , Pavla Krizova , Agnes Lepoutre , Jolita Mereckiene , Didrik F Vestrheim , Pilar Ciruela , Maria Ordobas , Marcela Guevara , Eisin McDonald , Eva Morfeldt , Jana Kozakova , Emmanuelle Varon , Suzanne Cotter , Brita A Winje , Carmen Munoz-Almagro , Luis Garcia , Jesus Castilla , Andrew Smith , Birgitta Henriques-Normark , Lucia Pastore Celentano , Germaine Hanquet

The Streptococcus pneumoniae Invasive Disease network (SpIDnet) actively monitors populations in nine sites in seven European countries for invasive pneumococcal disease. Five sites use 13-valent pneumococcal conjugate vaccine (PCV13) alone and four use the ten-valent PCV (PCV10) and PCV13. Vaccination uptake is greater than 90% in six sites and 67-78% in three sites. We measured the effects of introducing high-valency PCVs on the incidence of invasive pneumococcal disease in children younger than 5 years.

中文翻译:

高效率肺炎球菌结合疫苗对SpIDnet国家儿童侵袭性肺炎球菌疾病的影响:一项观察性多中心研究。

肺炎链球菌侵袭性疾病网络(SpIDnet)积极监测七个欧洲国家/地区中九个地点的人群是否患有侵袭性肺炎球菌疾病。五个地点仅使用13价肺炎球菌结合疫苗(PCV13),四个地点使用十价PCV(PCV10)和PCV13。六个地点的疫苗接种率大于90%,三个地点的疫苗接种率大于67-78%。我们测量了引入高价PCV对5岁以下儿童侵袭性肺炎球菌疾病发生率的影响。
更新日期:2017-08-10
down
wechat
bug